This country profile provides an overview of Rwanda’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 3/100
Overall rank: Joint 33rd

Treatment coverage

Lymphatic filariasis
N/A
Onchocerciasis
N/A
Schistosomiasis
0%
STH
100%
Trachoma
N/A
4.38 million people received treatment in Rwanda in 2016 810,000 people in need did not receive treatment in Rwanda in 2016

Rwanda recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Given the high coverage of soil-transmitted helminths (STH) preventive chemotherapy (PC) already achieved, implement PC for schistosomiasis alongside STH, at least for school-aged children and start elimination mapping for onchocerciasis.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

Rwanda does not require mass treatment for lymphatic filariasis.

Onchocerciasis

Rwanda does not require mass treatment for onchocerciasis.

Schistosomiasis

⬇️ Treatment coverage decreased from 23% in 2015 to 0% in 2016.

School-aged children needing treatment
969,000
School-aged children receiving treatment
0 reported

Soil-transmitted helminths

⬆️ Treatment coverage increased from 99% in 2015 to 100% in 2016.

Pre-sch and school-aged children needing treatment
4.38m
Pre-school and school-aged children receiving treatment
4.38m

Trachoma

Rwanda does not require mass treatment for trachoma.